KPTI Karyopharm Therapeutics Inc. Forecast, Technical & Fundamental Analysis
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more
KPTI is expected to report earnings to rise 5.65% to -130 cents per share on July 30
Q2'26
Est.
$-1.31
Q1'26
Missed
by $1.15
Q4'25
Missed
by $5.48
Q3'25
Missed
by $3.60
Q2'25
Missed
by $4.22
The last earnings report on May 14 showed earnings per share of -124 cents, missing the estimate of -9 cents. With 235.33K shares outstanding, the current market capitalization sits at 227.65M.
A.I. Advisor
published General Information
General Information
a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then ARRY could also see price increases.
KPTI in +11.95% Uptrend, growing for three consecutive days on June 26, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where KPTI advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 23, 2026. You may want to consider a long position or call options on KPTI as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for KPTI just turned positive on June 25, 2026. Looking at past instances where KPTI's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 124 cases where KPTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
KPTI broke above its upper Bollinger Band on July 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (22.885). P/E Ratio (0.000) is within average values for comparable stocks, (37.796). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.508). KPTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (0.997) is also within normal values, averaging (434.181).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KPTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
